Leach Jacob Steven 4

What Happened
Jacob Steven Leach, President, Chief Executive Officer and Director of DexCom, was granted 104,516 restricted stock units (RSUs) on March 8, 2026 (reported on Form 4 filed March 10, 2026). To satisfy tax withholding on the net settlement of RSUs, 19,757 shares were withheld at $68.10 per share, equal to $1,345,452. The RSUs were reported as an award (code A); the withholding is reported as a tax withholding/disposition (code F).

Key Details

• Transaction date: March 8, 2026; Form 4 filed March 10, 2026 (timely filing).
• Grant: 104,516 RSUs, $0 reported acquisition price; RSUs are subject to vesting.
• Tax withholding: 19,757 shares withheld at $68.10 = $1,345,452 (not an open-market sale by the insider).
• Vesting note: The RSUs are subject to vesting in three equal annual installments from the grant date (per footnote).
• Holdings detail: Reporting person has 148,536 unvested RSUs in total — 104,516 granted 3/8/2026 (vest through 3/8/2029), plus prior grants (23,937; 11,399; 8,684) with varying vesting schedules through 2027–2028.
• Trust note: Some shares are held by the Gregg Family Grandchildren's Trust (spouse is a trustee).
• Filing timeliness: Filed within the Section 16 reporting window (not indicated as late).

Context
This filing records an equity award (RSUs) and the routine net settlement/tax withholding of a portion of that award. The withheld shares are used to cover tax obligations and should not be interpreted as an open-market sale reflecting insider sentiment. The RSUs vest over future dates, so the grant represents future potential share delivery, not an immediate open-market purchase or investment by the insider.